Parkinson's Disease Treatment Cost in India

Parkinson's Disease treatment in India typically ranges from $500 to $6,000 USD, depending on the hospital, city, and type of procedure.

Parkinson's disease is a long-term condition, so the cost is best thought of per year rather than per procedure:

• Medical management: neurologist visits and daily medicines (levodopa-carbidopa and add-on drugs). An Indian study found a modest median annual direct cost of care, which rises as the disease advances.
• Therapies: physiotherapy, speech and occupational therapy, which matter more as the disease progresses.
• Device-aided treatment: deep brain stimulation (DBS) involves surgery and an implanted stimulator and battery. It is a separate and much larger package that should be quoted on its own.
• Diagnostic work-up: usually clinical; brain MRI excludes other causes, and dopamine transporter imaging is used only when the diagnosis is uncertain.

Confirm whether a quote is for a medication review visit, a year of care, or DBS surgery.

According to NINDS, carbidopa-levodopa is the main treatment, with other medicines added as needed:

• Levodopa-carbidopa: the most effective medicine for movement symptoms.
• Dopamine agonists, MAO-B and COMT inhibitors, amantadine: used early or to smooth fluctuations.
• Later challenges: 'wearing off' between doses and involuntary movements (dyskinesia), managed by adjusting timing and combinations.
• Exercise and therapy: regular exercise improves balance, flexibility and strength and is part of treatment.

DBS is usually considered when medicines still work but cause troublesome fluctuations or dyskinesia, or when tremor does not respond to medication.

• Who benefits: people with a clear response to levodopa, without significant dementia or uncontrolled psychiatric illness.
• What it helps: tremor, stiffness, slowness and fluctuations.
• What it does not help: NINDS notes DBS does not improve speech problems, freezing, balance and posture problems, or mood and memory.
• After surgery: several programming visits over the following months to tune the stimulator, plus battery replacement or recharging over time.

A one- to two-week visit can confirm the diagnosis, optimise medicines and, if relevant, complete DBS assessment, including a levodopa challenge test and neuropsychology review.

• Non-motor symptoms: constipation, sleep problems, low blood pressure on standing, mood changes and memory problems deserve treatment too.
• Medicine supply: check that prescribed brands are available at home; do not stop levodopa abruptly.
• DBS follow-up: programming can be done remotely or locally only if a trained team and compatible equipment are available.

Indian hospitals commonly advertise savings of 60% to 80% compared with the United States, UK, or private Middle Eastern centers. Treat that as a general comparison rather than a verified figure for this treatment, and compare itemised written quotes.